EAM Global Investors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-277,151
| Closed | -$4.75M | – | 83 |
|
|
2024
Q4 | $4.75M | Sell |
277,151
-126,820
| -31% | -$2.17M | 0.85% | 58 |
|
|
2024
Q3 | $8.08M | Sell |
403,971
-257,018
| -39% | -$5.14M | 1.63% | 6 |
|
|
2024
Q2 | $7.39M | Sell |
660,989
-110,574
| -14% | -$1.24M | 1.66% | 8 |
|
|
2024
Q1 | $5.09M | Buy |
+771,563
| New | +$5.09M | 1.18% | 34 |
|
|
2023
Q4 | – | Sell |
-632,352
| Closed | -$2.26M | – | 103 |
|
|
2023
Q3 | $2.26M | Buy |
+632,352
| New | +$2.26M | 0.61% | 91 |
|
|
2023
Q1 | – | Sell |
-836,323
| Closed | -$3.24M | – | 84 |
|
|
2022
Q4 | $3.24M | Hold |
836,323
| – | – | 0.84% | 26 |
|
|
2022
Q3 | $2.03M | Hold |
836,323
| – | – | 0.54% | 68 |
|
|
2022
Q2 | $1.66M | Buy |
+836,323
| New | +$1.66M | 0.41% | 117 |
|